Search results
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 2 weeks agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 29, 2023 – Zacks.com announces the list of stocks...
Merck and Block have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – July 18, 2022 – Zacks Equity Research shares Merck & Co. MRK as...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 1 month agoMerck MRK reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks...
Merck's (MRK) Keytruda Early-Stage NSCLC Study Shows OS Benefit
Zacks via Yahoo Finance· 8 months agoMerck MRK announced that a pivotal phase III study evaluating its blockbuster PD-L1 inhibitor,...
Merck (MRK) Gets CHMP Nod for Expanded Use of Antiviral Drug
Zacks via Yahoo Finance· 8 months agoMerck MRK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer Use
Zacks via Yahoo Finance· 5 months agoFDA approves Merck's (MRK) Keytruda plus chemoradiotherapy (CRT) for patients with FIGO 2014 Stage...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 1 month agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Merck (MRK) Q3 Earnings Top Estimates, COVID Drug Boosts Sales
Zacks via Yahoo Finance· 7 months agoMerck MRK reported adjusted earnings of $2.13 per share for third-quarter 2023, beating the Zacks...
Merck (MRK) Beats on Q1 Earnings and Sales, Ups 2023 View
Zacks via Yahoo Finance· 1 year agoMerck MRK reported first-quarter 2023 adjusted earnings of $1.40 per share, which beat the Zacks...